Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

1472 - Dedicated breast PET for predicting residual disease after breast cancer neoadjuvant chemotherapy

Date

11 Sep 2017

Session

Poster display session

Presenters

Shinsuke Sasada

Citation

Annals of Oncology (2017) 28 (suppl_5): v43-v67. 10.1093/annonc/mdx362

Authors

S. Sasada1, T. Kadoya2, N. Goga1, A. Emi1, K. Kajitani1, N. Masumoto1, R. Haruta3, T. Kataoka3, M. Okada1

Author affiliations

  • 1 Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 734-8551 - Hiroshima/JP
  • 2 Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima/JP
  • 3 Breast Surgery, Hiroshima University Hospital, 734-8551 - Hiroshima/JP
More

Resources

Abstract 1472

Background

Diagnostic methods to evaluate the response to breast cancer neoadjuvant chemotherapy (NAC) have been established. Dedicated breast PET (DbPET) is a high-resolution molecular breast imaging method, and we investigated the ability of DbPET to predict the presence of residual primary tumors after NAC, compared with whole-body PET (WBPET).

Methods

Forty-five patients (47 tumors) underwent WBPET and ring-type DbPET after NAC, and tumors were completely resected between January 2016 and March 2017. The pathological response was classified as complete remission (ypT0), residual intraductal disease (ypTis), or residual invasive disease (ypT≥1). Standardized uptake value (SUV) and tumor-to-normal tissue ratio (TNR) were assessed.

Results

Twelve patients achieved ypT0 and 5 developed ypTis. DbPET detected all cases of ypTis, and WBPET detected only one case of ypTis. The sensitivity, specificity, and accuracy of WBPET for ypT≥is were 54.3%, 83.3%, and 61.7%, respectively, and those of DbPET were 77.1%, 83.3%, and 78.7%, respectively. In the ypT0/ypTis/ypT≥1 groups, the median WBPET-SUV, DbPET-SUV, and DbPET-TNR were 1.0/0.9/1.1, 1.7/1.8/2.2, and 1.0/1.6/1.7 (P = .134, .077, and .008), respectively (Table). Area under the curves of WBPET-SUV, DbPET-SUV, and DbPET-TNR for predicting ypT≥is were 0.610, 0.648, and 0.807, respectively.Table:

210P Comparison of predicting indexes for predicting pathological response

Pathological response WBPET-SUVDbPET-SUVDbPET-TNR
Median (IQR)p Median (IQR)p Median (IQR)p
ypT≥11.1 (0.9-1.7).1342.2 (1.5-3.9).0771.7 (1.1-2.9).008
ypTis0.9 (0.9-1.2)1.8 (1.4-1.9)1.6 (1.4-1.8)
ypT01.0 (0.9-1.0)1.7 (1.5-2.1)1.0 (0.9-1.1)

Conclusions

DbPET was superior to detect residual primary tumors, especially noninvasive carcinoma, after NAC than WBPET. TNR was expected as the better parameter of pathological evaluation than SUV.

Clinical trial identification

Legal entity responsible for the study

N/A

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.